Snowball logo
logo
RASP

Rasna Therapeutics Inc

RASP • PINK
$0.0005$0.00  (0%)
Estimate
Beta
-84.208
About the company
Ticker
RASP
ISIN
US7538881068
Country
United States of America
Sector (GICS)
Healthcare
Actavia Life Sciences, Inc., a leukemia-focused biotechnology company, develops therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma in the United States. It is developing RASP-201, an orally dosed selective reversible inhibitor of lysine specific demethylase (LSD1), which is a pathway that blocks differentiation and confers a poor prognosis to AML; and RASP-301. The company was formerly known as Rasna Therapeutics, Inc. and changed its name to Actavia Life Sciences, Inc. in October 2023. Actavia Life Sciences, Inc. was founded in 2013 and is based in New York, New York.

Frequently asked questions

What sector does Rasna Therapeutics Inc (RASP) operate in?

Rasna Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Rasna Therapeutics Inc (RASP) current stock price?

As of the latest data, Rasna Therapeutics Inc stock price is $0.00, with a previous close of $0.00.

What is Rasna Therapeutics Inc (RASP) current market capitalization?

Rasna Therapeutics Inc market cap is approximately 385.91 thousand.

Does Rasna Therapeutics Inc (RASP) pay dividends?

No. Rasna Therapeutics Inc does not pay a dividend.

What is Rasna Therapeutics Inc (RASP) beta (volatility) score?

Rasna Therapeutics Inc has a beta of -84.208, indicating lower volatility than the overall market.